Professor Peter Winstanley is the Chair of Faculty of Medicine, Warwick Medical School. Born and raised in Liverpool, Professor Winstanley graduated from Liverpool Medical School in 1979, and undertook his first training posts locally before moving to the Royal Postgraduate Medical School and the Brompton Hospital. After spells in the General Infirmary at Leeds and the University of Liverpool, he was awarded an MRC Training Fellowship, and spent 3-years working in Kenya (with the University of Oxford) on the treatment of severe malaria.
Returning to Liverpool in 1992 as a Senior Lecturer in Clinical Pharmacology, Professor Winstanley continued his interest in falciparum malaria and maintained his research presence in Kenya. In 1995 Professor Winstanley and colleagues won support from the Wellcome Trust to establish a Wellcome Trust Tropical Centre (WTTC) at Liverpool, and he worked with Professors Malcolm Molyneux and (more recently) Robert Heyderman to develop the unit in Malawi into a Wellcome Trust Major Overseas Programme. As Director of the WTTC 1995 to 2009 Peter oversaw 27 Clinical Fellowships and the retention of 10 of these scientists by Liverpool (2 with clinical chairs). The award of a Wellcome Trust Clinical PhD Programme in 2008 (one of 7 nationally) will see a further 15 Clinical Fellowships made available in the following 5-years, all addressing 'Health Priorities of the Developing World'
Since 2007 Professor Winstanley has directed the Liverpool Biomedical Research Centre (supported by the National Institute of Clinical Research (NIHR)). The Liverpool BRC focuses on translational aspects of Microbial Diseases and is built around a novel 'managed portfolio' of projects which has annual external oversight including Cornell and the Centers for Disease Control.
Professor Winstanley joined Warwick from his role as Head of the School of Clinical Sciences at Liverpool, a post he held from 2007. This School (a part of the Faculty of Health & Life Sciences) spans Biomedicine through Translational Medicine to Health Service Research.
- Rénia, Laurent, Premji, Zul, Umeh, Rich Enujioke, Owusu-Agyei, Seth, Esamai, Fabian, Ezedinachi, Emmanuel U., Oguche, Stephen, Borrmann, Steffen, Sowunmi, Akintunde, Duparc, Stephan, Kirby, Paula L., Pamba, Allan, Kellam, Lynda, Guiguemdé, Robert, Greenwood, Brian, Ward, S. A., Winstanley, Peter, 2009. Chlorproguanil-Dapsone-Artesunate versus Artemether-Lumefantrine : a randomized, double-blind phase III trial in African children and adolescents with uncomplicated plasmodium falciparum malaria. PLoS One, 4 (8)
- Tiono, A. B., Dicko, A., Ndububa, D. A., Agbenyega, T., Pitmang, S., Awobusuyi, J., Pamba, A., Duparc, S., Goh, L.-E., Harrell, E., Carter, N., Ward, S. A., Greenwood, B., Winstanley, Peter, 2009. Chlorproguanil-Dapsone-Artesunate versus Chlorproguanil-Dapsone : a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene, Vol.81 (No.6), pp. 969-978
- Bell, David J., Wootton, Daniel G., Mukaka, Mavuto, Montgomery, Jacqui, Kayange, Noel, Chimpeni, Phillips, Hughes, Dyfrig, Molyneux, Malcolm E., Ward, Steve A., Winstanley, Peter, Lalloo, David G., 2009. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malaria Journal, Vol.8 (No.204)
- Wootton, Daniel G., Opara, Hyginus, Biagini, Giancarlo A., Kanjala, Maxwell K., Duparc, Stephan, Kirby, Paula L., Woessner, Mary, Neate, Colin, Nyirenda, Maggie, Blencowe, Hannah, Dube-Mbeye, Queen, Kanyok, Thomas, Ward, Stephen, Molyneux, Malcolm E., Dunyo, Sam, Winstanley, Peter, 2008. Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap?) alone or with three different doses of artesunate for uncomplicated plasmodium falciparum malaria. PLoS One, Vol.3 (No.3)
- Ochong, Edwin, Bell, David J., Johnson, David J., D'Alessandro, Umberto, Mulenga, Modest, Muangnoicharoen, Sant, Van Geertruyden, Jean-Pierre, Winstanley, Peter, Bray, Patrick G., Ward, Stephen A., Owen, Andrew, 2008. Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure. Antimicrobial Agents and Chemotherapy, Vol.52 (No.11), pp. 3883-3888
- Bell, David J., Nyirongo, Suzgo K., Mukaka, Mavuto, Zijlstra, Ed E., Plowe, Christopher V., Molyneux, Malcolm E., Ward, Steve A., Winstanley, Peter, 2008. Sulfadoxine-pyrimethamine?based combinations for malaria : a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi. PLoS ONE, Vol.3 (No.2)
|Title||Funder||Award start||Award end|
|Wellcome Trust Value in People Award 2010-11||Wellcome Trust||01 Oct 2010||30 Sep 2011|
|Wellcome Trust Value in People Award - Medical School share||Wellcome Trust||01 Oct 2010||30 Sep 2011|
|NIHR Senior Inverstigator Award||National Institute for Health Research (DoH)||07 Feb 2011||31 Mar 2011|